Inventor · disambiguated record
Raygene Michaël Martier
Also filed as: MARTIER RAYGENE MICHAEL · MARTIER RAYGENE MICHAËL
0 granted patents·4 pending applications·0 citations·filing 2019–2024
Technology areasC12N
Files withUNIQURE IP BV4
Top patents by PatentIndex Score
4 records- 0174US2024398988A1RNAi induced C9ORF72 suppression for the treatment of ALS/FTDUNIQURE IP BV·Filed 2024·Application pending·0 cites
- 0260US2022010314A1Rnai induced reduction of ataxin-3 for the treatment of spinocerebellar ataxia type 3UNIQURE IP BV·Filed 2021·Application pending·0 cites
- 0360US2021330813A1Rnai induced c9orf72 suppression for the treatment of als/ftdUNIQURE IP BV·Filed 2021·Application pending·0 cites
- 0456US2020199625A1RNAi induced reduction of ataxin-3 for the treatment of Spinocerebellar ataxia type 3UNIQURE IP BV·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Raygene Michaël Martier files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →